Comments for Columbus Day Dash & Slash features DEPO, VVUS, ONCY and RDNT at http://www.biomedreports.com , comment 1 to 1 out of 1 comments http://www.biomedreports.com Wed, 08 Feb 2012 18:25:27 +0100 FeedCreator 1.7.3 http://www.biomedreports.com/2009101212819/columbus-day-dash.html#comment-1764 Based on techical analysis alone, VVUS (Vivus) looks good that it has formed a flag and pennant and seemingly has broken above the trend. Vivus has created the obesity medication Qnexa® which has been submitted to the FDA for approval. But be aware... the FDA could reject it. This would probably cause the stock to tumble. When would this happen, look towards the later part of 2010 to hear from the FDA according to. [url]http://www.tesofensine-information.com/qnexa.html[/url] Also note that there are 3 other obesity medications that will all be under watch at the same time, those are Qnexa as well as Contrave and Lorcaserin. Keep an eye on how those fair as well... - Jon Jones Wed, 06 Jan 2010 04:24:06 +0100